1-Imidazoleacetic Acidum CAS 22884-10-2 Puritas ≥99.0% (GC) Acidum Zoledronicum Intermedia Featured Image

1-Imidazoleacetic Acidum CAS 22884-10-2 Puritas ≥99.0% (GC) Acidum Zoledronicum Intermedium

Description:

Nomen chemicum: 1-Imidazoleaceticum acidum

CAS: 22884-10-2

Puritas: ≥99.0% (GC)

Aspectus: Alba ad lux Yellow Crystal pulveris

Medium Acidum Zoledronici (CAS: 118072-93-8)

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Manufacturer Supple, Puritas, Commercial Productio
Nomen chemicum: 1-Imidazoleaceticum Acidum CAS: 22884-10-2

Chemical Properties:

Nomen chemicum	1-Imidazoleacetic Acidum
Synonyma	Imidazol-1-yl-Acetic Acidum;1H-Imidazole-1-acetic Acidum;2-(1-Imidazolyl) Acidum aceticum;1-(Carboxymethyl)imidazole
CAS Number	22884-10-2
CATTUS Number	RF-PI976
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C5H6N2O2
M. Pondus	126.12
Liquescens punctum	258℃
Solubilitas	Solutum in aqua
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba ad lux Yellow Crystal pulveris
Puritas / Analysis Methodus	≥99.0% (GC)
Damnum in Siccatio	≤0.50%
Totalis immunditias	≤1.0%
Test Standard	Enterprise Standard
Consuetudinem	Pharmaceutical intermedia

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;A luce et humore protege.

commoda:

FAQ:

Applicatio:

1-Imidazoleacetic Acidum (CAS: 22884-10-2) adhibetur ut medium acidum Zoledronici (CAS: 118072-93-8).Acidum zoledronicum, bisphosphonatum, a FDA in MMI US probatum est propter hypercalcemiam malignitatis tractandam, complicationem metabolicam quae vitam minare potest.Hypercalcemia malignitatis fieri potest usque ad 50% aegrorum praecogniti cum cancro pectoris provecto, myeloma multiplex, et nonsullis cellulis pulmonis cancri.Haec conditio oritur, cum medietates chemicae per tumorem osteoclastarum causam productae sunt.